# cefepime

NDC: 25021-121
Generic name: cefepime hydrochloride
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20080501

FDA application: ANDA065441

## Active ingredients

- CEFEPIME HYDROCHLORIDE: 1 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-121"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-121
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de477f37-40f6-4295-ae72-a2ee36a8922e